Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-week randomized double-blind pregabalin dose-response study in idiopathic restless legs syndrome
2008-000025-19Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pregabalin in restless legs syndrome (RLS) (2 arms), sponsored by Pfizer. Primary endpoint: Change from baseline in IRLS total score at week 6 by dose level. Started Mar 2008; status: completed.
02
Drugs
pregabalin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2008-000025-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000025-19.